以色列 - 希伯来文 - Ministry of Health

neopharm (israel) 1996 ltd - glucose as monohydrate 10 % - solution for injection - glucose - fluid adn nutrient replenishment.

以色列 - 希伯来文 - Ministry of Health

neopharm (israel) 1996 ltd - sodium chloride 0.9 g / 100 ml - solution for injection - sodium chloride - vehicle for therapeutic regimen. balance restoration (chloride + sodium). extracellular dehydration. hypovolaemia.

以色列 - 希伯来文 - Ministry of Health

neopharm (israel) 1996 ltd - sodium chloride - תמיסה להזרקה - sodium chloride 0.45 g / 100 ml - sodium chloride - sodium chloride - supply of water for administration of electrolytes. vehicle for therapeutic regimen.

以色列 - 希伯来文 - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride 27 mg / 100 ml; lactic acid as sodium 0.533 g / 100 ml - solution for injection - combinations of electrolytes - isotonic injectable solution.

以色列 - 希伯来文 - Ministry of Health

neopharm consumer products ltd, israel - polyethylene glycol 3350 - אבקה להכנת תרחיף - polyethylene glycol 3350 99.973 %w/w - macrogol - macrogol - treatment of constipation.

以色列 - 希伯来文 - Ministry of Health

neopharm ltd - polidocanol; soya oil - תמיסה - soya oil 82.95 g / 100 g; polidocanol 15 g / 100 g - polidocanol - polidocanol - refatting medical oil bath with antipruritic effect.

以色列 - 希伯来文 - Ministry of Health

neopharm ltd - erythromycin - תמיסה - חיצוני - erythromycin 2 % - erythromycin - erythromycin - all forms of acne, particularly inflammatory forms with papules and pustules.

以色列 - 希伯来文 - Ministry of Health

neopharm ltd - erythromycin; tretinoin - תמיסה - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

以色列 - 希伯来文 - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

以色列 - 希伯来文 - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.